Why is the going up and will go up at least another x 10 to x15 min27 Jan 2025 14:14
Tim McCarthy, CEO of ImmuPharma, joins us to discuss how the company is revolutionizing healthcare with peptide-based therapies. With its lead asset, P140, advancing in Phase 3 trials for lupus (Lupuzor™️) and pivotal Phase 2/3 trials for CIDP, ImmuPharma is pushing the boundaries of innovation in autoimmune and inflammatory disease treatments, leveraging proprietary technology and strategic partnerships to expand its pipeline.